糖心易測
Published by:
The University of Hong Kong
Description
糖心易測
糖心易測（HK CRISPS 風險評估工具）可評估（1）糖尿病，（2）心臟病發作或中風和（3）癌症的風險，這是根據一個建立於1995年，以香港人口為基礎的前瞻性研究，香港心血管疾病風險因素普查的長期數據制定出來，參與者年齡介乎在25至74歲。
（1）糖尿病
簡易糖尿病評分（NDS）是為非糖尿病患者篩查患有隱形糖尿病的風險評估。該分數是根據你的年齡、體重指標及血壓水平來評估你的風險。
（2）心臟病發作或中風
此風險評估的前設是沒有心臟病發作或中風的病史，根據性別、吸煙狀況、體重指標、血壓、血糖以及膽固醇水平推算你未來10年患上心臟病發作（又稱急性心肌梗塞）或中風之風險。
（3）癌症
此風險評估的前設是沒有患癌的病史，根據年齡、體重指標和吸煙狀況推算你未來10年患癌症的風險，並與你同年齡和性別、不吸煙及體重指標正常的人士對照。
Show More...
糖心易測（HK CRISPS 風險評估工具）可評估（1）糖尿病，（2）心臟病發作或中風和（3）癌症的風險，這是根據一個建立於1995年，以香港人口為基礎的前瞻性研究，香港心血管疾病風險因素普查的長期數據制定出來，參與者年齡介乎在25至74歲。
（1）糖尿病
簡易糖尿病評分（NDS）是為非糖尿病患者篩查患有隱形糖尿病的風險評估。該分數是根據你的年齡、體重指標及血壓水平來評估你的風險。
（2）心臟病發作或中風
此風險評估的前設是沒有心臟病發作或中風的病史，根據性別、吸煙狀況、體重指標、血壓、血糖以及膽固醇水平推算你未來10年患上心臟病發作（又稱急性心肌梗塞）或中風之風險。
（3）癌症
此風險評估的前設是沒有患癌的病史，根據年齡、體重指標和吸煙狀況推算你未來10年患癌症的風險，並與你同年齡和性別、不吸煙及體重指標正常的人士對照。
Screenshots
糖心易測 FAQ
-
Is 糖心易測 free?
Yes, 糖心易測 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 糖心易測 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
-
How much does 糖心易測 cost?
糖心易測 is free.
-
What is 糖心易測 revenue?
To get estimated revenue of 糖心易測 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
5 out of 5
6 ratings in Hong Kong SAR China
5 star
6
4 star
0
3 star
0
2 star
0
1 star
0
Ratings History
糖心易測 Reviews
App doesn't have any reviews yet
Store Rankings
Ranking History
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
133
|
糖心易測 Competitors
糖心易測 Installs
Last 30 days
糖心易測 Revenue
Last 30 days糖心易測 Revenue and Downloads
Gain valuable insights into 糖心易測 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
The University of Hong Kong
- Languages
- English
- Recent release
- 2 (1 year ago )
- Released on
- Oct 5, 2020 (4 years ago )
- Also available in
- Hong Kong SAR China, Peru, Kuwait, Mexico, Malaysia, Nigeria, Netherlands, Norway, New Zealand, Japan, Russia, Saudi Arabia, Singapore, Thailand, Türkiye, Taiwan, Ukraine, United States, United Arab Emirates, Italy, India, Ireland, Hungary, Spain, Egypt, Ecuador, Algeria, Germany, China, Chile, Canada, Brazil, Australia, Austria
- Last Updated
- 5 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.